HKG Epitherapeutics Launches Genetic Methylation Test
The genetic test evaluates specific genes that offer individuals insights into their genetic profiles and their effects on health and aging.
Read MorePosted by Andy Lundin | Jan 31, 2024 | Cancer |
The genetic test evaluates specific genes that offer individuals insights into their genetic profiles and their effects on health and aging.
Read MorePosted by Andy Lundin | Jan 30, 2024 | Leukemia |
A pilot study proposes a promising clinically applicable genomic assay for the diagnosis of a heterogeneous pediatric leukemia.
Read MorePosted by Andy Lundin | Jan 29, 2024 | Unknown Origin & Other Cancer Types |
The study will collect small blood samples several times from 150 patients with high-risk neuroblastoma to be examined in laboratories.
Read MorePosted by Andy Lundin | Jan 24, 2024 | Prenatal Testing |
Natera has acquired certain assets from Invitae relating to its non-invasive prenatal screening and carrier screening business.
Read MorePosted by Andy Lundin | Jan 24, 2024 | Diagnostic Technologies |
New software combines AI and machine learning to measure the significance of specific genomic biomarkers to predict diseases in individuals.
Read More